Investor relations

Carasent offers mission-critial solutions like Electronic Health Records (EHR), Medical Clinic Management Software, patient engagement solutions, and business intelligence tools across various health and care sectors. In a world where efficiency and sustainability are paramount, Carasent ASA is at the forefront of providing solutions that alleviate the burden on the health and care systems.

Key figures in 2022

0 M
NOK in Revenue
0 %
Adj. ebitda Margin
0 %
Organic growth
0 M
NOK ARR Dec 2022
0 M
NOK Cash Balance

Interim report Q3, 2023

Annual report 2022

Capital Markets Day 2023

On November 7th 2023, Carasent hosted a Capital Markets Day at Carnegie head office in Stockholm. If you missed the event, you can view the recorded webcast and the presentation here:

Financial calendar

Quarterly Report Q4 2024

Presentation of earnings Q4

Quarterly Report Q3 2024

Presentation of Q3 earnings

Half-yearly Report 2024

Presentation of half-yearly report

Quarterly Report Q1 2024

Presentation of earnings Q1

Stock exchange releases

Annual and quarterly reports

Other reports and documents

Carasent Transparency Act Report 2023

Calling Notice – Annual Shareholder Meeting, 3 May 2023

Senior Management Remuneration Report 2022

Mandate for the nomination committee

Subscribe to our pressreleases

Are you curious to hear more?